Hendrayana, T.; Wilmer, A.; Kurth, V.; Schmidt-Wolf, I.G.; Jaehde, U.
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Sci. Pharm. 2017, 85, 8.
https://doi.org/10.3390/scipharm85010008
AMA Style
Hendrayana T, Wilmer A, Kurth V, Schmidt-Wolf IG, Jaehde U.
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Scientia Pharmaceutica. 2017; 85(1):8.
https://doi.org/10.3390/scipharm85010008
Chicago/Turabian Style
Hendrayana, Tomi, André Wilmer, Verena Kurth, Ingo GH Schmidt-Wolf, and Ulrich Jaehde.
2017. "Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application" Scientia Pharmaceutica 85, no. 1: 8.
https://doi.org/10.3390/scipharm85010008
APA Style
Hendrayana, T., Wilmer, A., Kurth, V., Schmidt-Wolf, I. G., & Jaehde, U.
(2017). Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Scientia Pharmaceutica, 85(1), 8.
https://doi.org/10.3390/scipharm85010008